Abstract
Menogaril, an anthracycline derivative, has been shown to possess antitumor activity in experimental animal systems, and is now under phase II clinical studies. However, its mechanism of action has not been elucidated. We have found that it inhibits the decatenation activity of purified DNA topoisomerase II using kinetoplast DNA from Crithidia fasciculata, its IC50 being 10 μM, which is comparable to that of etoposide. It does not, however, inhibit topoisomerase I activity at concentrations of up to 400 μM. Binding of topoisomerase II with DNA is not affected, but cleavable complex formation is stimulated by the drug. Cleavage site specificity differes from that of 4′‐(9‐acridinylamino)methanesulfon‐m‐anisidide. Menogaril was shown to possess a weak double‐helix unwinding activity. These findings allow us to classify menogaril as a cleavable complex‐stabilizing topoisomerase II inhibitor.
Keywords: Key words, Menogaril Anthracycline, Topoisomerase II, Cleavable complex, DNA unwinding activity
Full Text
The Full Text of this article is available as a PDF (704.6 KB).
REFERENCES
- 1. ) Wang , J. C.DNA topoisomerases . Annu. Rev. Biochem. , 54 , 665 – 697 ( 1985. ). [DOI] [PubMed] [Google Scholar]
- 2. ) Vosberg , H.‐P.DNA topoisomerases: enzymes that control DNA conformation . Curr. Top. Microbiol Immunol , 114 , 19 – 102 ( 1985. ). [DOI] [PubMed] [Google Scholar]
- 3. ) Wang , J. C.DNA topoisomerases: why so many ? J. Biol Chem. , 266 , 6659 – 6662 ( 1991. ). [PubMed] [Google Scholar]
- 4. ) Liu , L. F.DNA topoisomerase poisons as antitumor drugs . Annu. Rev. Biochem. , 58 , 351 – 375 ( 1989. ). [DOI] [PubMed] [Google Scholar]
- 5. ) Crooke S. T. and Reich S. D. ( ed. ). “ Anthracyclines: Current Status and New Developments ” ( 1980. ). Academic Press; , New York . [Google Scholar]
- 6. ) Lown J. W. ( ed. ). “ Anthracyclines and Anthracenedione Based Anticancer Agents ” ( 1988. ). Elsevier, Inc. , Amsterdam . [Google Scholar]
- 7. ) Neil , G. L. , Keuntzel , S. L. and McGovren , J. P.Treatment of mouse tumors with 7‐con‐O‐methylnogarol and other analogs of anthracycline antibiotic nogalamycin . Cancer Treat. Rep. , 39 , 4818 – 4822 ( 1979. ). [PubMed] [Google Scholar]
- 8. ) Kreuger , W. C. , Pschigoda , L. M. , Schpok , S. L. F. , Moscotitz , A. , McGovren , J. P. , Neta , P. , Merritt , M. V. and Li , L. H.The interaction of nogalamycin and analogs with DNA and other biopolymers . Chem. Biol Interact. , 36 , 1 – 18 ( 1981. ). [DOI] [PubMed] [Google Scholar]
- 9. ) Egorin , M. J. , Clawson , R. E. , Cohen , J. L. , Ross , L. A. and Bachur , N. R.Cytofluorescence localization of anthracycline antibiotics . Cancer Res. , 40 , 4669 – 4676 ( 1980. ). [PubMed] [Google Scholar]
- 10. ) Bhuyan , B. K. , McGovren , J. P. and Crampton , S. L.Intracellular uptake of 7‐con‐O‐methylnogarol and adriamycin by cells in culture and its relationship to cell survival . Cancer Res. , 41 , 882 – 887 ( 1981. ). [PubMed] [Google Scholar]
- 11. ) Wierzba , K. , Sugimoto , Y. , Matsuo , K. , Toko , T. , Takeda , S. , Yamada , Y. and Tsukagoshi , S.Menogaril, an anthracycline compound with a novel mechanism of action: cellular pharmacology . Jpn. J. Cancer Res. , 81 , 842 – 849 ( 1990. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. ) Ishii , K. , Hasegawa , T. , Fujisawa , K. and Andoh , T.Rapid purification and characterization of DNA topoisomerase I from cultured mouse mammary carcinoma FM3A cells . J. Biol. Chem. , 258 , 12728 – 12732 ( 1983. ). [PubMed] [Google Scholar]
- 13. ) Halligan , B. D. , Edwards , K. A. and Liu , L. F.Purification and characterization of a type II DNA topoisomerase from bovine calf thymus . J. Biol. Chem. , 260 , 2475 – 2482 ( 1985. ). [PubMed] [Google Scholar]
- 14. ) Tanabe , K. , Ikegami , Y. , Ishida , R. and Andoh , T.Inhibition of topoisomerase II by antitumor agents, bis(2,6‐dioxopiperazine) derivatives . Cancer Res. , 51 , 4903 – 4908 ( 1991. ). [PubMed] [Google Scholar]
- 15. ) Miller , K. G. , Liu , L. F. and England , P. T.A homogeneous type II DNA topoisomerase from HeLa cell nuclei . J. Biol. Chem. , 256 , 9334 – 9339 ( 1981. ). [PubMed] [Google Scholar]
- 16. ) McConaughy , B. L. , Young , L. S. and Champoux , J. J.The effect of salt on the binding of the eukaryotic DNA nicking closing enzyme to DNA and chromatin . Biochim. Biophys. Acta , 655 , 1 – 8 ( 1981. ). [DOI] [PubMed] [Google Scholar]
- 17. ) Liu , L. F. , Rowe , T. C. , Yang , L. , Tewey , K. M. and Chen , G. L.Cleavage of DNA by mammalian DNA topoisomerase II . J. Biol. Chem. , 258 , 15365 – 15370 ( 1983. ). [PubMed] [Google Scholar]
- 18. ) Hsiang , Y. , Hertzberg , R. , Hecht , S. and Liu , L. F.Camptothecin induces protein‐linked DNA breaks via mammalian DNA topoisomerase I . J. Biol Chem. , 260 , 14873 – 14878 ( 1985. ). [PubMed] [Google Scholar]
- 19. ) Nelson , E. M. , Tewey , K. M. and Liu , L. F.Mechanism of antitumor drug action: poisoning of mammalian DNA topoisoase II on DNA by 4′‐(9‐acridinylamino)‐methanesulfon‐m‐anisidide . Proc. Natl. Acad. Sci. USA , 81 , 1361 – 1365 ( 1984. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. ) Bodley , A. , Liu , L. F. , Israel , M. , Seshadri , R. , Koseki , Y. , Guiliani , F. C. , Kirschenbaum , S. , Silber , R. and Potmesil , M.DNA topoisomerase II‐mediated interaction of doxorubicin and daunorubicin congeners with DNA . Cancer Res. , 49 , 5969 – 5978 ( 1989. ). [PubMed] [Google Scholar]
- 21. ) Pommier , Y. , Covey , J. M. , Kerrigan , D. , Markovits , J. and Pham , R.DNA unwinding and inhibition of mouse leukemia L1210 DNA topoisomerase I by intercalators . Nucleic Acids Res. , 15 , 6713 – 6731 ( 1987. ). [DOI] [PMC free article] [PubMed] [Google Scholar]